News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
201 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (21820)
Month
January (2488)
February (2603)
March (3228)
April (2950)
May (3962)
June (3500)
July (2854)
August (3142)
September (3205)
October (3540)
November (3386)
December (2332)
Day
1 (247)
2 (234)
3 (123)
4 (6)
5 (2)
6 (157)
7 (294)
8 (215)
9 (227)
10 (147)
11 (6)
12 (2)
13 (213)
14 (201)
15 (161)
16 (149)
17 (68)
19 (2)
20 (132)
21 (113)
22 (70)
23 (4)
24 (6)
26 (9)
27 (154)
28 (186)
29 (127)
30 (131)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
24
26
27
28
29
30
FDA
Mortise Medical Receives FDA Clearance for SyndesMetrics Syndesmosis Repair System
The Mortise Medical SyndesMetrics Syndesmosis Repair System was developed to address three clinical needs for syndesmotic disruption injuries: predictable and repeatable anatomic reduction, restoration of physiological motion, and restoration of ankle stability.
November 14, 2017
·
2 min read
Business
Fluxion Biosciences Appoints Harvard Bioscience as North American Distributor
Fluxion Biosciences today announced that it has signed a distribution agreement with Harvard Biosciences.
November 14, 2017
·
2 min read
Genetown
Trinity Partners Reveals Findings on FDA-Approved Novel Drug Performance
Trinity Partners announced the findings of its second annual Trinity Drug Index which assessed all novel drugs approved by the FDA in 2014.
November 14, 2017
·
2 min read
Policy
Scilex Pharma, Sorrento’s Subsidiary, Files MAA in the European Union for ZTlido
Sorrento announced today that Scilex Pharma filed the European MAA for its lead product candidate, ZTlido through a hybrid regulatory pathway with the MHRA in the UK.
November 14, 2017
·
4 min read
Business
Bernoulli Health Collaborates With GE Healthcare to Enable Interoperability
Bernoulli Health announced today collaboration with GE Healthcare on the new CARESCAPE Connect data aggregation solution.
November 14, 2017
·
2 min read
Medigate Announces $5.35M Seed Round to Protect Connected Medical Devices from Pandemic Cyberattacks Threatening Patient Safety and Privacy
The Medigate solution is a dedicated platform for securing networked medical devices that are connected to electronic medical records, device servers, other enterprise systems and the internet.
November 14, 2017
·
8 min read
Pharm Country
Purdue Pharma L.P. Announces Strategic Investment in Oncology R&D
Purdue Pharma, L.P. today announced completion of significant oncology related investments as part of its ongoing efforts to diversify its scientific research into areas of high unmet medical need.
November 14, 2017
·
4 min read
Eyetronic Therapy: New Study Proves Long-Term Effect
A recent study led by Prof. Dr. Carl Erb[*] shows that the treatment with the Eyetronic system resulted in a stop of the progression of glaucoma in approximately 75% of patients one year after the therapy.
November 14, 2017
·
3 min read
Biotech Bay
Vector Labs Introduces First Effective Reagent for Autofluorescence Quenching
TrueVIEW is effective across the spectral range from blue to far red and is compatible with commonly used fluorophores.
November 14, 2017
·
2 min read
Business
Soleno Therapeutics Provides Corporate Update and Reports Third Quarter 2017 Financial Results
Net loss for the third quarter of 2017 was $3.8 million, or $0.35 per share, compared to a net loss of $2.8 million, or $0.87 per share, for the third quarter in 2016.
November 14, 2017
·
12 min read
Previous
10 of 21
Next